01 August 2010
Protective action of hepatocyte growth factor on transforming growth factor beta-1-induced alpha-smooth muscle actin and extracellular matrix in cultured human peritoneal fibroblasts
Dapeng JiangADEG, Changqing XuBDF, Zhaozhu LiBC, Yubo ZhangBCE, Fuyou HanBF, Zhitao JiangBCEMed Sci Monit 2010; 16(8): BR250-254 :: ID: 881097
Abstract
Background: Peritoneal adhesion is the leading cause of severe mechanical bowel obstruction, female infertility, pelvic pain, and difficult surgical procedures. TGF-beta1 plays an important role in matrix production associated with postoperative peritoneal adhesion development. Recent investigators have shown that HGF works on several organs and has been given widespread attention because it has proved to have strong antifibrotic activity. The aim of this study was to determine the impact of HGF on markers of adhesion formation induced by TGF-beta1 in human peritoneal fibroblasts.
Material/Methods: Fibroblasts were collected from normal peritoneum and were cultured with 5 ng/ml of TGF-beta1 along with increasing doses of HGF (10–40 ng/ml). Expression of α-SMA was assessed by Western blot. The productions of collagen I and fibronectin in supernatants culture were examined by enzyme-linked immunosorbent assay (ELISA).
Results: TGF-beta1 significantly stimulated α-SMA, collagen I and fibronectin production in peritoneal fibroblasts. Remarkably, the addition of HGF reduced production of all components induced by TGF-beta1 in a dose-dependent manner.
Conclusions: This study suggests that HGF may be a novel, highly efficacious agent in the minimization of intra-abdominal adhesion. Although further studies are needed to assess the mechanisms of HGF in neutralizing the effect of TGF-beta1, these findings also provide a cellular and molecular basis for the action of HGF as an anti-adhesion agent.
Keywords: Peritoneum - cytology, Protective Agents - pharmacology, Hepatocyte Growth Factor - pharmacology, Fibronectins - biosynthesis, Fibroblasts - metabolism, Extracellular Matrix - metabolism, Collagen Type I - biosynthesis, Transforming Growth Factor beta1 - pharmacology
Editorial
01 May 2024 : Editorial
Editorial: First Regulatory Approval for Adoptive Cell Therapy with Autologous Tumor-Infiltrating Lymphocytes (TILs) – Lifileucel (Amtagvi)DOI: 10.12659/MSM.944927
Med Sci Monit 2024; 30:e944927
In Press
12 Mar 2024 : Clinical Research
Preoperative Blood Transfusion Requirements for Hemorrhoidal Severe Anemia: A Retrospective Study of 128 Pa...Med Sci Monit In Press; DOI: 10.12659/MSM.943126
12 Mar 2024 : Clinical Research
Tissue Inhibitors of Metalloproteinase 1 (TIMP-1) and 3 (TIMP-3) as New Markers of Acute Kidney Injury Afte...Med Sci Monit In Press; DOI: 10.12659/MSM.943500
12 Mar 2024 : Review article
Optimizing Behçet Uveitis Management: A Review of Personalized Immunosuppressive StrategiesMed Sci Monit In Press; DOI: 10.12659/MSM.943240
12 Mar 2024 : Clinical Research
Metabolomic Alterations in Methotrexate Treatment of Moderate-to-Severe PsoriasisMed Sci Monit In Press; DOI: 10.12659/MSM.943360
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952